Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different approaches to assess extracellular vesicles from bovine colostrum.

JDS communications·2026
Same author

Molecular engineering of aggregation-induced emission enhanced photosensitizers to boost the theranostic performance in photodynamic therapy.

Journal of materials chemistry. B·2026
Same author

Cell swelling and upright mounting-based imaging for high-resolution visualization of intracellular trafficking across the BBB using conventional confocal microscopy.

Drug delivery·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Ultrabright NIR-II Nanoprobes for <i>Ex</i> <i>Vivo</i> Bioimaging: Protein Nanoengineering Meets Molecular Engineering.

ACS nanoscience Au·2025
Same author

Epidural pre-formed long-acting implants as a novel and challenging approach for brain drug delivery.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Related Experiment Video

Updated: Jun 27, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.

Young Tag Ko1, Raktima Bhattacharya, Ulrich Bickel

  • 1Department of Pharmaceutical Sciences, Texas Tech University Health Science Center, Amarillo, 79106, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|November 18, 2008
PubMed
Summary

PEGylated liposomes encapsulate polyethylenimine/oligodeoxynucleotide polyplexes, enhancing systemic circulation and reducing RES uptake. This novel delivery system shows potential for targeted in vivo nucleic acid delivery, including to the brain.

More Related Videos

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

Related Experiment Videos

Last Updated: Jun 27, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

Assembly and Characterization of Polyelectrolyte Complex Micelles
08:44

Assembly and Characterization of Polyelectrolyte Complex Micelles

Published on: March 2, 2020

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Drug Delivery Systems

Background:

  • Cationic polymer polyethylenimine (PEI) shows high in vitro transfection but limited systemic application due to rapid blood clearance and RES accumulation.
  • Improving PEI/DNA polyplex properties is crucial for extended circulation time and suppressed RES uptake in systemic delivery.

Purpose of the Study:

  • To develop a PEGylated liposome system for enhanced systemic delivery of PEI/oligodeoxynucleotide (ODN) polyplexes.
  • To evaluate the biodistribution and circulation time of ODN delivered via PEGylated liposomes.

Main Methods:

  • PEI/ODN polyplexes were encapsulated into PEGylated liposomes (PSL) with high loading efficiency, forming virus-like structures (~130 nm).
  • Stability of PSL in serum and the pharmacokinetic profile of entrapped ODN after intravenous administration were assessed.
  • Targeting PSL with transferrin receptor antibodies was used to redirect biodistribution.

Main Results:

  • PEGylated liposomes entrapping PEI/ODN polyplexes demonstrated stability in serum.
  • PSL significantly slowed the clearance rate of ODN from systemic circulation compared to naked PEI/ODN.
  • Targeted PSL showed significant ODN accumulation in the brain via transferrin receptor.

Conclusions:

  • Encapsulating PEI/ODN polyplexes within long-circulating PEGylated liposomes offers a promising strategy for in vivo ODN delivery.
  • This approach overcomes limitations of PEI, enabling improved systemic circulation and targeted organ accumulation.